Does Dr. ANDREW WHITELEY have financial conflicts of interest?

Dr. ANDREW WHITELEY (MD) has received a total of $1,574,258 in pharmaceutical and medical device industry funding between 2021 and 2025. This includes $1,574,258 in personal promotional payouts (consulting, meals, travel) and $0 in clinical research grants. Financial ties do not automatically imply conflict of interest, but are disclosed under the Sunshine Act.

Which pharmaceutical companies pay Dr. ANDREW WHITELEY?

According to CMS Open Payments data, Dr. ANDREW WHITELEY received funding from SEAGEN ($1,020,604), GLAXOSMITHKLINE ($195,501), and BEIGENE USA ($178,353).

Does Dr. ANDREW WHITELEY receive research grants or speaking fees?

Dr. ANDREW WHITELEY has received $1,574,258 in general promotional payments (such as consulting honoraria, meals, and speaking fees) and $0 in clinical research grants.

DR. ANDREW WHITELEY

MDReal-Time Hydrated

Specialty: Internal Medicine, Medical Oncology

Practice Location: DALLAS, TX 75246

NPI Number: 1225328743

LIFETIME INDUSTRY VALUE

$1,574,258

2021 – 2025 Cumulative

Conflict of Interest Analysis

Dr. WHITELEY is a verified Internal Medicine, Medical Oncology practitioner based in DALLAS, TX.

Between 2021 and 2025, Dr. WHITELEY had an overall industry promotional and research financial footprint of $1,574,258 as recorded in the federal CMS Open Payments database.

$1,574,258 was received in general payments, which include consultation fees, travel expenses, honoraria, and sponsored meals.
$0 was allocated to sponsored clinical trials and medical research activities.

Dr. WHITELEY's primary funding source is SEAGEN, which accounts for $1,020,604 (representing 64.8% of overall industry footprint).

Data coverage: 2021 – 2025 · Source: CMS Open Payments · CMS publishes each year's data around June 30 of the following year.

Payout Trend Over Time

General Payments

Research Funding

Top Funding Entities

Pharmaceutical & Device Manufacturers making direct payments

SEAGEN

Rank 1

$1,020,604

64.8%

GLAXOSMITHKLINE

Rank 2

$195,501

12.4%

BEIGENE USA

Rank 3

$178,353

11.3%

Itemized Transaction Archives

Direct live query to Socrata CMS Open Payments API (Bypasses local DB)

Year:

2025

Filter < $250

Click "Load Live Logs" to query the federal Open Payments registry directly.

Frequently Asked Questions

Answers compiled using federal transparency disclosure records under the Sunshine Act.